Skip to content
Lucky Services Blog

Prestigious Prize Honors Groundbreaking Body's Defenses Research

The Nobel Prize in Physiology or Medicine has been awarded for transformative findings that clarify how the immune system targets harmful pathogens while sparing the healthy tissues.

A trio of esteemed researchers—Japan's Shimon Sakaguchi and American experts Dr. Brunkow and Fred Ramsdell—received this honor.

The research identified unique "sentinels" within the immune system that remove malfunctioning immune cells that could attacking the organism.

The discoveries are now enabling innovative treatments for autoimmune diseases and malignancies.

These winners will share a prize fund worth 11m Swedish kronor.

Crucial Discoveries

"Their work has been essential for comprehending how the body's defenses operates and the reason we don't all suffer from serious autoimmune diseases," stated the chair of the Nobel Committee.

The team's studies address a core mystery: How does the defense system defend us from numerous infections while leaving our healthy cells intact?

Our immune system uses white blood cells that search for indicators of disease, including viruses and germs it has not met before.

These cells employ detectors—known as receptors—that are produced randomly in countless combinations.

That gives the defense network the capacity to fight a broad range of threats, but the randomness of the mechanism unavoidably creates immune cells that may attack the body.

Protectors of the Body

Researchers earlier understood that a portion of these problematic defense cells were destroyed in the thymus—the site where immune cells mature.

The latest award recognizes the discovery of T-reg cells—described as the immune system's "security guards"—which travel through the system to neutralize any immune cells that assault the healthy cells.

We know that this process fails in autoimmune diseases such as type-1 diabetes, multiple sclerosis, and rheumatoid arthritis.

The Nobel panel added, "These discoveries have laid the foundation for a new field of research and spurred the creation of new treatments, for example for tumors and autoimmune diseases."

Regarding malignancies, T-regs block the system from attacking the tumor, so studies are aimed at reducing their numbers.

In autoimmune diseases, trials are exploring increasing regulatory T-cells so the body is not under attack. A similar approach could also be useful in minimizing the chances of organ transplant failure.

Innovative Experiments

Professor Shimon Sakaguchi, of a Japanese institution, conducted tests on mice that had their immune gland removed, leading to autoimmune disease.

He showed that introducing defense cells from healthy mice could stop the illness—suggesting there was a system for blocking defenders from harming the body.

Dr. Brunkow, affiliated with the Institute for Systems Biology in a US city, and Dr. Ramsdell, currently at Sonoma Biotherapeutics in San Francisco, were investigating an inherited autoimmune disease in rodents and humans that resulted in the identification of a gene vital for the way T-regs operate.

"The pioneering research has uncovered how the body's defenses is kept in check by T-reg cells, preventing it from mistakenly targeting the healthy cells," commented a prominent physiology expert.

"This research is a striking illustration of how basic biological study can have far-reaching implications for human health."

By

James Orr

A tech enthusiast and IT consultant with over 8 years of experience in digital solutions and cybersecurity.

Lucky Services Blog

Type to search articles.